COVID-19 Funding (06-25-2020)

Jun 25, 2020, 15:22 PM by Melodi Moore

COVID-19 exclusively directed funding is becoming less prevalent as more sponsors merge the funds available with their general grant funds. The Research Resource Blog will continue to bring you a list of COVID-19 funds available, but we recommend that you also peruse all other posted funding announcements. If you find a posted announcement that is no longer available, please email us at ResearchOffice@utmb.edu.

Merck KGaA Darmstadt Germany has issued a RFP that considers projects that leverage technological solutions to be more prepared for pandemic outbreaks or solutions that could help to fight emerging viral infections.

Pre-outbreak R&D Preparedness for pandemic disease:

Assessing the priority of pathogens and diseases with epidemic threat
Platform technologies to accelerate the development of vaccines, drugs, diagnostics, vector control tools and delivery systems needed to control emerging health threats
Innovative technologies for better personal protection equipment for infection control

Response during outbreak:

Novel health technologies (e.g. AI, bioelectronics, diagnostics) for early screening of potential infected patients and treatment facilitation.
Fast-track identifying, testing and production of effective drugs and vaccines during outbreak

This is an immediate open call and a deadline has not been set. The grant will be 500,000 €/year for 3 years with the option of extension.

Community Interventions to Address the Consequences of the COVID-19 Pandemic among Health Disparity and Vulnerable Populations (R01- Clinical Trial Optional)

This Funding Opportunity Announcement (FOA) encourages applications to implement and evaluate community interventions testing 1) the impacts of mitigation strategies to prevent COVID-19 transmission in NIH-designated health disparity populations and other vulnerable groups; and 2) already implemented, new, or adapted interventions to address the adverse psychosocial, behavioral, and socioeconomic consequences of the pandemic on the health of these groups.

Deadline(s): August 28/December 1, 2020

NIA Multi-site COVID-19 Related Clinical Trial Implementation Grant on Aging-Related Topics in at-risk Older Adult Populations (R01 Clinical Trial Required)

This Funding Opportunity Announcement (FOA) invites applications for implementation of investigator-initiated multi-site clinical trials (all phases or stages) of interventions focused on specific aging-related issues to reducing transmission, risk, morbidity, mortality, severity, or complications of Coronavirus Disease 2019 (COVID-19).

Priorities include:

Efficacy and safety of interventions that target aging-related biological mechanisms that may influence risk or severity of COVID-19 infection among at-risk older adults
Efficacy and safety of preventive and treatment interventions in older patients with differing comorbid conditions that make them especially vulnerable to adverse outcomes of COVID-19 infection
Effectiveness of health and/or custodial care practices to reduce transmission risk or improve outcomes of COVID-19 infection in nursing homes or other residential settings serving at-risk older persons, including the development and testing of infection control training procedures for healthcare workers
Rapid pragmatic trials in (at least two) health systems, nursing homes, or adult living facilities, ensuring replication across large pragmatic trial sites and leveraging electronic health records to promote quality improvement in physician, hospital, palliative care, and hospice practices to improve outcomes for older patients with COVID-19, especially those with cognitive impairment, Alzheimer's disease or Alzheimer's disease-related dementias (AD/ADRD), or underlying comorbidities
Trials in at-risk older adults age 65 and older for whom electronic medical records are available and long-term outcomes can be tracked, and in institutions serving those populations
Trials in older adults with AD/ADRD, older adults from populations with NIH-defined health disparities, and/or other vulnerable populations (e.g. incarcerated, homeless, living in institutions)

Applications Due: July 1, 2020; August 3, 2020; September 1, 2020; October 1, 2020; November 2, 2020; December 1, 2020; January 4, 2021; and February 1, 2021.

Funding Opportunity for COVID-19-Related Enhancements to Existing PCORI-Funded Research Projects

PCORI seeks investigator-initiated proposals to address the COVID-19 public health crisis through enhancements of currently funded PCORI research awards. Only PCORI-funded principal investigators with active research project funding contracts are eligible to submit a proposal in response to this announcement.

Please Note: We understand that many current research awards will require adjustments to enable the projects to proceed and to produce meaningful findings. While this announcement is not intended to solicit requests for modifications intended primarily to enable achievement of original, planned aims, we are committed to facilitating these types of modifications and suggest that awardees consult PCORI’s COVID-19 FAQs for guidance and for contact information to address these types of modifications and any related questions.

For Engagement Awardees: Click here to access the Engagement Enhancement Funding Opportunity.
For D&I Awardees: Click here to access the D&I Enhancement Funding Opportunity.

Applications will be considered on a rolling basis through the
deadline of Friday, July 17, 2020, at 5:00 p.m. ET.

Agency	Opp Number	Name of solicitation	Application Due Date	Notes
NEW/REVISED
Posted
NIH Multiple IC	PAR-20-237	Community Interventions to Address the Consequences of the COVID-19 Pandemic among Health Disparity and Vulnerable Populations (R01- Clinical Trial Optional)	August 28, 2020; December 1, 2020
NIH Multiple IC	NOT-OD-20-119	Notice of Special Interest (NOSI): Emergency Competitive Revisions for Social, Ethical, and Behavioral Implications (SEBI) Research on COVID-19 Testing among Underserved and/or Vulnerable Populations	Rolling - First available July, 8 2020
NIH Multiple IC	NOT-OD-20-120	Notice of Special Interest (NOSI): Emergency Competitive Revisions for Community-Engaged Research on COVID-19 Testing among Underserved and/or Vulnerable Populations	Rolling - First available July, 8 2020
DARPA, Army, CBD, DHA, DTRA, MDA, NAVY, SCO and USSOCOM	SBIR/STTR BAA	SBIR/STTR BAA	Multiple Dates via Agency	See also Army, CBD, DHA, DTRA, MDA, NAVY, SCO and USSOCOM opportunities of this announcement. https://rt.cto.mil/rtl-small-business-resources/sbir-sttr/
Cisco.com	RFP-20-04	Pandemic/COVID19 Science, Technology and Social Impact	Immediate
Data.org	Inclusive Growth and Recovery Challenge	Inclusive Growth and Recovery Challenge	Phase I open now
Microsoft	Mobilizing AI for Health to fight against COVID-19	Mobilizing AI for Health to fight against COVID-19	15-Jul-20
NIH FUNDING
NIH	RFA-RM-20-020	NIH Director’s Emergency Transformative Research Awards (R01 Clinical Trial Optional)	30-Sep-20
NIDCR	NOT-DE-20-025	Availability of Frequently Asked Questions (FAQs) for Coronavirus Disease 2019 (COVID-19)-Related Notices of Special Interest (NOSI) NOT-DE-20-022 and NOT-DE-20-023	N/A	Guidance to previous NOSI
NIGMS	NOT-GM-20-033	Availability of Urgent Award for Competitive Revisions to IDeA-CTR Awards to Address the Need for Documenting 2019 Novel Coronavirus Disease (COVID-19)-Related Patient Outcomes	18-Jun-20	Eligible applicants are awardees with an active NIGMS IDeA-CTR U54 award.
NIH Office of Director	NOT-OD-20-105	NIH Late Application Policy for Institutional Training Grants to PA-20-142 and PA-20-162 Due to Public Health Emergency for United States Coronavirus Disease 2019 (COVID-19)	Ongoing
NIH Multiple Institutions	PAR-20-180	Identifying Innovative Mechanisms or Interventions that Target Multimorbidity and Its Consequences (R01 Clinical Trial Optional)	5-Oct-20	Standards R01 due dates will apply
NIAID	RFA-CA-20-038	Emergency Awards: SARS-CoV-2 Serological Sciences Centers of Excellence (U54 Clinical Trial Optional)	22-Jul-20
NIAID	RFA-CA-20-039	Emergency Awards: Research Projects in SARS-CoV-2 Serological Sciences (U01 Clinical Trial Optional)	22-Jul-20
NIAID NIMH NIA NIDA NINDS	NOT-MH-20-048	Notice of Special Interest (NOSI): Chimerism in Marmosets and other New World Primates	05-Oct-20 through 08-Jan-22
NIDCR ORWH	NOT-DE-20-022	Notice of Special Interest (NOSI): Availability of Urgent Competitive Revisions and Administrative Supplements for Coronavirus Disease 2019 (COVID-19) Research within the Mission of NIDCR	1-Jun-20 2-Nov-2020
NIDCR	NOT-DE-20-022	Notice of Special Interest (NOSI): Availability of Urgent Competitive Revisions and Administrative Supplements for Coronavirus Disease 2019 (COVID-19) Research within the Mission of NIDCR	Rolling Submissions 01-Jun thru 02-Nov-20	Urgent need for research on Coronavirus Disease 2019
NCI	NOT-CA-20-054	Notice of Information: Contributing to the Global COVID-19 Crisis Response by Allowing Some NCI-supported Projects to be Redirected to COVID-19-related Research During the Crisis	N/A	The option provided in this Notice is only for the duration of the current COVID-19 crisis. Once routine access to institutional facilities is again available, NCI grantees will be expected to resume their funded research. A Notice will be published when the present opportunity is no longer in effect.
NHLBI	NOT-HL-20-782	Notice of Special Interest (NOSI): Availability of Emergency Competitive Revisions on Coronavirus Disease 2019 (COVID-19) for Currently Active NHLBI Phase I-III Clinical Trials	Rolling Submission through 10/05/2020
NIAID	PAR-20-177	Emergency Awards: Rapid Investigation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) (R21 Clinical Trial Not Allowed)	Rolling Submission
NIAID	PAR-20-178	Emergency Awards: Rapid Investigation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) (R01 Clinical Trial Not Allowed)	Rolling Submission
NIBIB	POCTRN Fast-Track	Rapid Acceleration of Diagnostics (RADx)		RAPID RESPONSE!
NIDDK	NOT-DK-20-026	Notice of Additional Activity Code Accepted for "NOT-DK-20-018, Notice of Special Interest (NOSI): Availability of Urgent Competitive Revision Supplements on Coronavirus Disease 2019 (COVID-19) within the Mission of NIDDK"	Continuous Submission	Adds U24 code to Coronavirus (COVID-19) Supplements
NINDS	NOT-NS-20-051	Notice of Special Interest (NOSI): Availability of Urgent Competitive Revisions and Administrative Supplements For Research on Biological Effects of the 2019 Novel Coronavirus on the Nervous System	Rolling Submission
Common Fund	NOT-RM-20-016	Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement - Clinical Trial Optional)	Continuous Submissions	Common fund participation in PA-20-135
NCATS	PAR-18-332	Clinic Testing Therapeutic/Indication Pairing Strategies (U01 Clinical Trial Required)	Standard NIH U01 dates
NIAAA	NOT-AA-20-011	Availability of Administrative Supplements and Competitive Revision Supplements on Coronavirus Disease 2019 (COVID-19) within the Mission of NIAAA	Continuous Submissions	NIAAA participation in PA-18-591 & PA-18-935
NIDCR	NOT-DE-20-020	NIDCR Participation in PA-18-935 “Urgent Competitive Revision to Existing NIH Grants and Cooperative Agreements (Urgent Supplement - Clinical Trial Optional)	Continuous Submissions	NIDCR participation in PA-18-935
NLM	NOT-LM-20-010	Availability of Administrative Supplements for Research on Coronavirus Disease 2019 (COVID-19)	Continuous Submissions	NLM participation in PA-18-591
NCCIH NIA NIAAA	NOT-AT-20-011	Administrative Supplements and Urgent Competitive Revisions for Research on Stress Management in Relation to Coronavirus Disease 2019 (COVID-19)	Continuous Submissions
NCI	NOT-CA-20-042	National Cancer Institute Announcement Regarding Availability of Urgent Competitive Revision and Administrative Supplements on Coronavirus Disease 2019 (COVID-19)	Continuous Submissions	NCI participation in PA-18-591 & PA-18-935
NIAAA	NOT-AA-20-007	Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement - Clinical Trial Optional")	Continuous Submissions	NIAAA participation in PA-20-135
NIBIB	NOT-EB-20-007	Development of Biomedical Technologies for Coronavirus Disease 2019 (COVID-19)	Continuous Submissions
NIDCD	NOT-DC-20-004	Availability of Urgent Competitive Revisions and Administrative Supplements for Research on Coronavirus Disease 2019 (COVID-19)	Continuous Submissions	NIDCD participation in PA-18-591 & PA-18-935
NIDDK	NOT-DK-20-018	Availability of Urgent Competitive Revision Supplements on Coronavirus Disease 2019 (COVID-19) within the Mission of NIDDK	Continuous Submissions	NIDDK participation in PA-18-935
NIMH	NOT-MH-20-041	Supporting Research Education in High-Priority Intervention and Services Research Areas for Mentoring Networks for Mental Health Research Education and Short Courses for Mental Health Related Research	Continuous Submissions
NIMH NIA NIAAA NIMHD ODP	NOT-MH-20-047	Administrative Supplements and Urgent Competitive Revisions for Mental Health Research on the 2019 Novel Coronavirus	Continuous Submissions
NIAID	NOT-AI-20-034	Availability of Emergency Competitive Revisions for Research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19)	25-Mar-21	Replaces NOT-AI-20-030 Continuous Submission
NIGMS	NOT-GM-20-025	Availability of Urgent Competitive Revisions for Research on Coronavirus Disease 2019 (COVID-19) and the Causative Virus SARS-CoV-2	5-Feb-21	Replaces NOT-AI-20-030 Continuous Submission
NCATS	NOT-TR-20-011	Clinical and Translational Science Award (CTSA) Program Applications to Address 2019 Novel Coronavirus (COVID-19) Public Heath Need	Dependent on Activity Code
NIA NIAID NIDDK NIDA NIMH NIEHS NICHD NIAAA	PA-18-935	Urgent Competitive Revision to Existing NIH Grants and Cooperative Agreements (Urgent Supplement - Clinical Trial Optional)	Continuous submission	Earliest start dates may vary by awarding IC. See the Urgent Guide Notices for any applicable Application Due Dates.
NIAID	PAR-18-781	Collaborative Cross (CC) Mouse Model Generation and Discovery of Immunoregulatory Mechanisms (R21 Clinical Trial Not Allowed)	9-Sep-20
NIAID	RFA-AI-20-028	Partnerships for Countermeasures against Select Pathogens (R01 Clinical Trials Not Allowed)	29-Jun-20	Mandatory LOI due 05/29/2020
Fogarty International Center		Ecology and Evolution of Infectious Diseases Initiative (EEID)	18-Nov-20
Multiple Institutes	PA-18-591	Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional)	Contact program Officer
NIAID NIGMS	NOT-AI-20-030	Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus (2019-nCoV)	Immediate
OTHER FEDERAL AGENCIES
DOE	Rapid Access for COVID-19 Research	Oak Ridge National Laboratory: Rapid Access for COVID-19 Research	Immediate	RAPID RESPONSE!
USDA	Agriculture and Food Research Initiative	Agriculture and Food Research Initiative Competitive Grants Program	Varies by Program Area	RAPID RESPONSE! Updated
Dept of Air Force	FA300220S0002	CSO_COVID_19 Response	30-Sep-20
AHRQ	PA-20-071	Announcement to Support Novel, High-Impact Studies Evaluating Health System and Healthcare Professional Responsiveness to COVID-19	Forecast July 2020 Deadline likely to fall in early-to-mid-summer	Lisa Scott-Morring 301-427-1544 Grant_Queries@ahrq.hhs.gov
CDC-ATSDR	CDC-RFA-TS20-20010101SUPP20	Partnership to Promote Local Efforts To Reduce Environmental Exposure - COVID-19 Supplement	6/30/2020	Trent LeCoultre 770-488-3799 tll7@cdc.gov
DOEd	ED-GRANTS-042120-004	Department of Health and Human Services	30-Sep-20
NSF	NSF 20-052	Rapid response grants to support coronavirus (COVID-19) research	Continuous Submissions
USDA	Distance Learning and Telemedicine Grants	Distance Learning & Telemedicine Grants	13-Jul-20	LIVE 04/15/2020
NSF	20-065	Request for SBIR/STTR Phase I Proposals Addressing COVID-19	Ongoing
PCORI	Comparative Effectiveness Research	Research, Implementation & Engagement Studies	1/12/2021
AHRQ	NOT-HS-20-007	Notice of Intent: Revision Supplements to Existing AHRQ Grants and Cooperative Agreements to Address Health System Responsiveness to COVID-19	FOA published early May	Address health system responsiveness to COVID-19.
AHRQ	NOT-HS-20-008	Notice of Intent: New Funding Opportunity Announcement to Support Novel, High-Impact Studies Evaluating Health System and Healthcare Professional Responsiveness to COVID-19	FOA published early May	Research focused on evaluating topics such as innovations and challenges encountered in the rapid expansion of telemedicine in response to COVID-19
DOL-ETA	ETA-TEGL-12-19	National Dislocated Worker Grants Program Guidance	N/A	Rolling submissions
HHS-NIH11	PAR-20-108	International Research in Infectious Diseases (R01 Clinical Trial Not Allowed)	19-Aug-22
Private Funding
DLA	DLA202-D013	Novel Approaches for Detection of and Protection from Emerging Viral Pandemics	2-Jul-20
Ferring Pharmaceuticals	COVID-19 Investigational Grants in Reproductive Medicine and Maternal Health	COVID-19 Investigational Grants in Reproductive Medicine and Maternal Health	Rolling Deadline through Oct. 31, 2020
Borealis Philanthropy	COVID-19 Collective Fund for Trans Communities	COVID-19 Collective Fund for Trans Communities	Open Ended Deadline
Global Outbreak Alert and Response Network	GOARN Request for Assistance	Help build capacity for the global COVID-19 pandemic response	Immediately
Amgen Foundation	COVID-19 Relief Support	COVID-19 Relief Support	Rolling Submissions	RAPID RESPONSE
Genome Canada	COVID-19 Regional Genomics Initiative	COVID-19 Regional Genomics Initiative	Immediately	Must work with Canadian PI
UK Research & Innovation	Research Grant	Research on COVID-19 and Ethnicity	Rolling call	Must work with UK PI
Gordon & Betty Moore Foundation	Diagnostic Excellence Initiative	Diagnostic Excellence Initiative	30-Jun-20
Novartis	Novartis COVID-19 Response Fund	Novartis COVID-19 Response Fund	TBA	Application details to come
Merck	2020 Research Grants	Pandemic preparedness / fighting new emerging viral infectious disease	31-Aug-20
Omidyar Network	COVID-19 Response	COVID-19 Economic Response Advocacy Fund Aims to Help Working Families Now, Create a Stronger, More Inclusive Economic System Moving Forward	Rolling Submissions	Campaigns that are already in motion and can leverage 501c4 dollars to capture the attention of policymakers and propel their ideas forward.
Nellie Mae Education Foundation	RFP	Rapid Response: Racism is a Virus Too	Ongoing	Projects that respond to the hate crimes and bias against Asian American communities resulting from COVID-19
U.S.-Israel Binational Science Foundation	Joint NSF-BSF Programs	Rapid Submission Research projects in Biology programs Dealing with the Coronavirus Disease	No Deadline
Private	Bloomberg Philanthropies	Coronavirus Local Response Initiative	Immediately	Continous Submission

Research at UTMB

Global web ALERT button

COVID-19 Funding (06-25-2020)